Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)

Nephrology Dialysis Transplantation

Volumn 30, Issue 3, 2015, Pages 366-375

  Herrmann, Sandra M S ^a   Saad, Ahmed ^a   Textor, Stephen C ^a  

^a MAYO CLINIC   (United States)

Author keywords

angioplasty; atherosclerosis; renal artery stenosis; renovascular hypertension; stent

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOPLASTY; ATHEROSCLEROTIC RENOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY SCINTISCANNING; LUNG EDEMA; NEPHROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RENAL ARTERY STENT; RENOVASCULAR DISEASE; REVASCULARIZATION; REVIEW; RISK FACTOR; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMPLICATION; DISEASE MANAGEMENT; KIDNEY ARTERY; KIDNEY DISEASE; PATHOPHYSIOLOGY; RENAL ARTERY OBSTRUCTION;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; HUMANS; KIDNEY DISEASES; RENAL ARTERY; RENAL ARTERY OBSTRUCTION;

EID: 84924349957     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu067     Document Type: Review

References (58)

1. Hansen KJ, Cherr GS, Dean RH. Dialysis-free survival after surgical repair of ischemic nephropathy. Cardiovasc Surg 2002; 10: 400-404
2. Ritchie J, Green D, Chrysochou C et al. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis 2014; 63: 186-197
3. Zoccali C, Mallamaci F, Finocchiaro P. Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol 2002; 13(Suppl. 3): S179-S183
4. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996-2000. AJR Am J Roentgenol 2004; 183: 561-568
5. Textor SC, Lerman LO. Reality and renovascular disease: when does renal artery stenosis warrant revascularization? Am J Kidney Dis 2014; 63: 175-177
6. Cooper CJ, Murphy TP, Cutlip DE et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014; 370: 13-22
7. Messina LM, Zelenock GB, Yao KA et al. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J Vasc Surg 1992; 15: 73-80; discussion 80-2
8. Krijnen P, van Jaarsveld BC, Steyerberg EW et al. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998; 129: 705-711
9. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens 2009; 27: 1333-1340
10. Imori Y, Akasaka T, Ochiai T et al. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. Am J Cardiol 2014; 113: 30-35
11. Yan JH, Sun LX, Zhao XY et al. Prevalence and risk factors of atherosclerotic renal artery stenosis. Zhonghua Yi Xue Za Zhi 2013; 93: 827-831
12. Rihal CS, Textor SC, Breen JF et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002; 77: 309-316
13. Kane GC, Xu N, Mistrik E et al. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010; 25: 813-820
14. de Silva R, Loh H, Rigby AS et al. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol 2007; 100: 273-279
15. Coen G, Manni M, Giannoni MF et al. Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am J Nephrol 1998; 18: 221-227
16. Goldblatt H, Lynch J, Hanzal RF et al. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59: 347-379
17. Loesch J. Ein Beitrag zur experimentellen Nephrtis und zum arteriellen Hochdruck III. Die Veranderungen in den Geweben. Zentralblatt Inn Med 1933; 7: 177-185
18. Basso N, Terragno NA. History about the discovery of the reninangiotensin system. Hypertension 2001; 38: 1246-1249
19. Messerli FH, Bangalore S, Makani H et al. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J 2011; 32: 2231-2235
20. Pickering TG, Herman L, Devereux RB et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 1988; 2: 551-552
21. Safian RD, Madder RD. Refining the approach to renal artery revascularization. JACC Cardiovasc Interv 2009; 2: 161-174
22. Textor SC, McKusick MM, Misra S et al. Timing and selection for renal revascularization in an era of negative trials: what to do? Prog Cardiovasc Dis 2009; 52: 220-228
23. Plouin PF, Chatellier G, Darne B et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-829
24. Webster J, Marshall F, Abdalla M et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12: 329-335
25. van Jaarsveld BC, Krijnen P, Pieterman H et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342: 1007-1014
26. Kaylor WM, Novick AC, Ziegelbaum M et al. Reversal of end stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion. J Urol 1989; 141: 486-488
27. Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 2005; 46: 776-783
28. Rocha-Singh KJ, Novack V, Pencina M et al. Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis. Catheter Cardiovasc Interv 2011; 78: 779-789
29. Ives NJ, Wheatley K, Stowe RL et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003; 18: 298-304
30. Kumbhani DJ, Bavry AA, Harvey JE et al. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J 2011; 161: 622-630e1
31. White CJ, Ramee SR, Collins TJ et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1997; 30: 1445-1450
32. Blum U, Krumme B, Flugel P et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997; 336: 459-465
33. Burket MW, Cooper CJ, Kennedy DJ et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000; 139 (1 Pt 1): 64-71
34. May AG, DeWeese JA, Rob CG. Hemodynamic effects of arterial stenosis. Surgery 1963; 53: 513-524
35. Wheatley K, Ives N, Gray R et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361: 1953-1962
36. Bax L, Woittiez AJ, Kouwenberg HJ et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009; 150: 840-848, W150-1
37. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-1312
38. Kalra PA, Chrysochou C, Green D et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv 2010; 75: 1-10
39. Jaff MR, Bates M, Sullivan T et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv 2012; 80: 343-350
40. Onuigbo MA. Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET-a call for more circumspection. QJM 2009; 102: 155-167
41. Herrmann SM, Textor SC. Diagnostic criteria for renovascular disease: where are we now? Nephrol Dial Transplant 2012; 27: 2657-2663
42. Gloviczki ML, Saad A, Textor SC. Blood oxygen level-dependent (BOLD) MRI analysis in atherosclerotic renal artery stenosis. Curr Opin Nephrol Hypertens 2013; 22: 519-524
43. Textor SC, Misra S, Oderich GS. Percutaneous revascularization for ischemic nephropathy: the past, present, and future. Kidney Int 2013; 83: 28-40
44. Modrall JG, Rosero EB, Smith ST et al. Operative mortality for renal artery bypass in the United States: results from the national inpatient sample. J Vasc Surg 2008; 48: 317-322
45. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM 1999; 92: 159-167
46. Gloviczki ML, Lerman LO, Textor SC. Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension. Curr Hypertens Rep 2011; 13: 370-377
47. Eirin A, Gloviczki ML, Tang H et al. Inflammatory and injury signals released from the post-stenotic human kidney. Eur Heart J 2013; 34: 540-548a
48. Eirin A, Gloviczki ML, Tang H et al. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. Nephrol Dial Dransplant 2012; 27: 4153-4161
49. Saad A, Herrmann SM, Crane J et al. Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate. Circ Cardiovasc Interv 2013; 6: 428-435
50. Gloviczki ML, Keddis MT, Garovic VD et al. TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol 2013; 8: 546-553
51. Dorros G, Jaff M, Mathiak L et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98: 642-647
52. Zhang MZ, Yao B, Yang S et al. CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest 2012; 122: 4519-4532
53. Eirin A, Zhu XY, Li Z et al. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol 2013; 33: 1006-1013
54. Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011; 80: 915-925
55. Lech M, Grobmayr R, Ryu M et al. Macrophage phenotype controls long-term AKI outcomes-kidney regeneration versus atrophy. J Am Soc Nephrol 2014; 25: 292-304
56. Eirin A, Zhu XY, Krier JD et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012; 30: 1030-1041
57. Eirin A, Li Z, Zhang X et al. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 2012; 60: 1242-1249
58. Hricik DE, Dunn MJ. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990; 1: 845-858